Wilson Therapeutics to present at the Carnegie Healthcare Seminar 2017
Jonas Hansson, Chief Executive Officer, will present Wilson Therapeutics at the Carnegie Healthcare Seminar 2017 on March 16 in Stockholm. The presentation will be held at 8:20 CET at Carnegie’s office at Regeringsgatan 56 in Stockholm, Sweden.About Wilson TherapeuticsWilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases. Wilson Therapeutics’ lead product, WTX101, is initially being developed as a novel treatment for Wilson Disease and has been evaluated in a Phase 2 clinical study. Wilson